AlphaYouIC
Schedule 13G filing
INTEGRATED CORE STRATEGIES (US) LLC disclosed a 5.7% stake in Karyopharm Therapeutics Inc. (KPTI)
INTEGRATED CORE STRATEGIES (US) LLC reported owning 5.7% of Karyopharm Therapeutics Inc. (KPTI) (1,297,297 shares) in a Schedule 13G filed Sep 4, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Sep 4, 2026
- Source
- Schedule 13G
More KPTI insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.